IP Library Granted Patent US 12,590,417
Granted Patent B2
US 12,590,417 · App. 18/545,976 · Granted Mar 31, 2026

Coreless rolls of a tissue paper product and methods of manufacturing coreless rolls

Inventors: Nicolas Weisang (Kunheim, FR); Sébastien Jeannot (Kunheim, FR)
Assignee: ESSITY HYGIENE AND HEALTH AKTIEBOLAG
D21H27/002D21H27/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,590,417
App. No.
18/545,976
Granted
Mar 31, 2026
Kind
B2
Abstract

A coreless roll of a tissue paper product has first and second ends, a web of absorbent material being wound to define an axially extending inner hole centrally positioned relative to the coreless roll, the product including at least two plies, at least one of which being an embossed ply, and the coreless roll having an outer diameter of 95-150 mm, an inner hole diameter being 20-50 mm, and a density of 110-160 kg/m 3 , the product including glued areas, and non-glued areas between the glued areas, at least some of the glued areas including embossments of the embossed ply, a sum of areas of all glued embossed areas being at least 6% of all glued areas and all non-glued areas over at least 80% of the glued embossed areas, a maximum distance between adjacent embossments of the embossed ply being 2.5 mm or less.

Claims (83)

1 . A method of manufacturing a coreless roll of a tissue paper product including one or a combination of toilet paper or household towel, the tissue paper product comprising at least two plies, wherein the method comprises the steps of:

feeding at least two plies and embossing at least one of the at least two plies to form an embossed ply, wherein all of the fed plies are made of Conventional Wet Press (CWP) paper;

ply-bonding the at least two plies using an adhesive including, a lamination glue, thereby forming glued areas and leaving non-glued areas between the glued areas, wherein at least some of the glued areas are glued embossed areas comprising embossments of the embossed ply, such that a sum of areas of all glued embossed areas is at least 6% of a sum of the areas of all glued areas and of areas of all non-glued areas, to form the tissue paper product;

spirally winding up the tissue paper product on a mandrel to form a coreless roll and to define an axially extending inner hole facing the mandrel, with a first end of the tissue paper product being located on the outer side of the coreless roll and the second end being located at the inner hole;

withdrawing the mandrel, wherein the coreless roll comprises an outer diameter in the range of from 95 to 150 mm and a diameter of the inner hole is in the range of from 20 to 50 mm, and the density of the coreless roll lies in a range of 110 to 160 kg/m 3 ;

wherein the steps of embossing and of ply-bonding are performed such that, over at least 80% of the glued embossed areas, a maximum distance between adjacent embossments of the embossed ply is 2.5 mm or less.

2 . The method of claim 1 , wherein the steps of embossing the at least one ply and of ply-bonding are performed such that, over at least 80% of the glued embossed areas, an embossment density of at least 20 embossments/cm 2 ,

the method comprising the step of providing at least 90% of the adhesive to tips of embossments of the embossed ply,

wherein the method comprises embossing the at least one ply with first embossments with a first embossment height and at least one further type of embossments with a height smaller than the first embossment height, and comprises providing at least 90% of the adhesive of the adhesive to tips of the first embossments of the embossed ply in the tissue paper product.

3 . The method of claim 1 , wherein the ply-bonding is performed to at least 80% of all areas of the embossed ply which have been embossed.

4 . The method of claim 1 , wherein the embossing to form the embossed ply comprises providing at least 25 embossments to at least 80% of all areas to be embossed and ply-bonded.

5 . The method of claim 1 , wherein the method comprises the step of coating at least a part of an innermost circumvolution of the absorbent material of the coreless roll at the second end with a stabilizing coating composition.

6 . The method of claim 1 , wherein the tissue paper product is manufactured to comprise exactly two plies, a first ply and a second ply, wherein the method comprises embossing the first ply and the second ply,

the density of the coreless roll lying in a range of 110 to 150 kg/m 3 ,

wherein the sum of the areas of all glued embossed areas is at least 6% of the sum of the areas of all glued areas and of all non-glued areas,

a caliper of the tissue paper product being at least 0.35 mm or at least 0.40 mm, and

a grammage of the tissue paper product being in a range of from 24 g/m 2 to 50 g/m 2 .

7 . The method of claim 6 , further including the steps of:

embossing the first ply to form first embossments with a first height (h 1 ), the first height (h 1 ) being in a range of 0.2 mm to 2.0 mm;

applying the adhesive to tips of the first embossments of the first ply;

embossing the second ply to form second embossments with a second height (h 2 ), the second height (h 2 ) being in a range of 0.2 mm to 2.0 mm;

embossing the first ply to form third embossments with a third height (h 3 ) smaller than the first height (h 1 ) (h 1 >h 3 ); and

embossing the second ply to form fourth embossments with a fourth height (h 3 ) smaller than the second height (h 2 ) (h 2 >h 4 ).

8 . The method of claim 1 , wherein the tissue paper product is manufactured to comprise exactly three plies, the embossed ply being an outermost ply,

the density of the coreless roll lying in a range of 130 to 160 kg/m 3 ,

wherein the sum of the areas of all glued embossed areas is at least 6% of the sum of the areas of all glued areas and of all non-glued areas, and

a caliper of the tissue paper product being at least 0.40 mm,

a grammage of the tissue paper product being in a range of from 34 g/m 2 to 65 g/m 2 .

9 . The method of claim 8 , wherein the three plies are a first ply, a second ply, and a third ply, and wherein the third ply is positioned between the first ply and the second ply, the method further including:

embossing the first ply to form first embossments with a first height (h 1 ), the first height (h 1 ) being in a range of 0.2 mm to 2.0 mm;

applying the adhesive to tips of the first embossments of the first ply;

embossing the second ply to form second embossments with a second height (h 2 ), the second height (h 2 ) being in a range of 0.2 mm to 2.0 mm;

embossing the first ply to form third embossments with a third height (h 3 ) smaller than the first height (h 1 ) (h 1 >h 3 ); and

embossing the second ply to form fourth embossments with a fourth height (h 3 ) smaller than the second height (h 2 ) (h 2 >h 4 ).

10 . The method of claim 8 , absent the step of embossing the third ply.

11 . The method of claim 8 , further including the steps of:

embossing the first ply and the third ply together to form the first embossments on the first ply and the third ply; and

one of forming the third embossments only on the first ply but not on the third ply, or, embossing the first ply and the third ply together to form the third embossments on the first ply and the third ply.

12 . The method of claim 8 , further including the step of:

embossing the third ply of form fifth embossments with a fifth height (h 5 ), the fifth height (h 5 ) being in a range of 0.2 mm to 2.0 mm, wherein the third ply has been embossed separately from the first ply and the second ply.

13 . The method of claim 1 , wherein the tissue paper product is manufactured to comprise exactly four plies,

the density of the coreless roll lying in a range of 130 to 160 kg/m 3 ,

wherein the sum of the areas of all glued embossed areas is at least 6% of the sum of the areas of all glued areas and of all non-glued areas, and

a caliper of the tissue paper product being at least 0.50 mm.

14 . The method of claim 13 , wherein the four plies are a first ply, a second ply, a third ply, and a fourth ply, wherein the first ply and the second ply are outermost plies of the tissue paper product, the method comprising the steps of:

embossing the first ply to form first embossments with a first height (h 1 ), the first height (h 1 ) being in a range of 0.2 mm to 2.0 mm;

applying the adhesive to tips of the first embossments of the first ply;

embossing the second ply to form second embossments with a second height (h 2 ), the second height (h 2 ) being in a range of 0.2 mm to 2.0 mm;

embossing the first ply to form third embossments with a third height (h 3 ) smaller than the first height (h 1 ) (h 1 >h 3 ); and

embossing the second ply to form fourth embossments with a fourth height (h 4 ) smaller than the second height (h 2 ) (h 2 >h 4 ).

15 . The method of claim 14 , further including embossing the first ply and the third ply together to form the first embossments on the first ply and the third ply,

the method not comprising a step of embossing the fourth ply, or the method comprising a step of embossing the fourth ply separately from the first ply, the second ply, and the third ply, and

the method comprising the step of forming the third embossments only on the first ply but not on the third ply, or of embossing the first ply and the third ply together to form the third embossments on the first ply and the third ply.

16 . The method of claim 14 , further including the steps of:

embossing the first ply, the third ply, and the fourth ply together to form the first embossments on the first ply, the third ply, and the fourth ply;

embossing the first ply, the third ply, and the fourth ply together to form the third embossments on the first ply, the third ply, and the fourth ply; or

forming the third embossments on the first ply and the third ply, but not on the fourth ply; or

forming the third embossments on the first ply, but not on the third ply and the fourth ply.

17 . The method of claim 14 , further including one of the steps comprising:

embossing the third ply and the fourth ply together separately from the first ply and the second ply; or

embossing one of the third ply and the fourth ply separately from the first ply and the second ply, and not embossing the other one of the third ply and the fourth ply; or

neither embossing the third ply nor the fourth ply.

18 . The method of claim 14 , further including the steps of:

embossing the first ply and the third ply together to form the first embossments on the first ply and the third ply;

embossing the fourth ply and the second ply together to form the second embossments on the fourth ply and the second ply; and

one of embossing the first ply and the third ply together to form the third embossments on the first ply and the third ply, or forming the third embossments only on the first ply but not on the third ply.

19 . The method of claim 1 , wherein the tissue paper product is manufactured to comprise exactly five or six plies, the density of the coreless roll lying in a range of 150 to 160 kg/m 3 ,

wherein the sum of the areas of all glued areas is at least 6% of the sum of the areas of all glued areas and of all non-glued areas, and

a caliper of the tissue paper product being at least 0.60 mm.

20 . The method of claim 19 , further including the steps of:

embossing at least one of the outermost plies of the tissue paper product to form first embossments with a first height (h 1 ), the first height (h 1 ) being in a range of 0.2 mm to 2.0 mm;

applying the adhesive to tips of the first embossments of the first ply; and

embossing the other one of the outermost plies of the tissue paper product to form second embossments with a second height (h 2 ), the second height (h 2 ) being in a range of 0.2 mm to 2.0 mm.

21 . A coreless roll of a tissue paper product including one or a combination of toilet paper or household towel, the tissue paper product made of a spirally wound continuous web of tissue paper having a first end and a second end, the web of absorbent material being wound to define an axially extending inner hole centrally positioned relative to the coreless roll and such that the first end is located on the outer side of the coreless roll and the second end is located at the inner hole,

wherein the tissue paper product comprises at least two plies, the at least two plies including at least a first ply and a second ply, being the outermost plies of the tissue paper product, wherein all of the plies of the tissue paper product are made of Conventional Wet Press (CWP) paper,

wherein the coreless roll has an outer diameter in the range of from 95 to 150 mm, a diameter of the inner hole being in the range of from 20 to 50 mm, and the density of the coreless roll being in a range of 110 to 160 kg/m 3 ,

wherein the first ply is embossed with first embossments and the second ply is embossed with second embossments,

the tissue paper product comprising glued areas and non-glued areas between the glued areas, where the plies are ply-bonded to each other using an adhesive,

wherein at least some of the glued areas are glued embossed areas that comprise first embossments of the first ply and second embossments of the second ply,

wherein a sum of areas of all glued embossed areas is at least 6% of a sum of the areas of all glued areas and of areas of all non-glued areas.

22 . The coreless roll of a tissue paper product of claim 21 ,

wherein the adhesive includes a lamination glue, and

wherein, over at least 80% of the glued embossed areas, a maximum distance between adjacent embossments of the embossed ply is 2.5 mm or less.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: WEISANG, NICOLAS; JEANNOT, SÉBASTIEN
To: ESSITY HYGIENE AND HEALTH AKTIEBOLAG
Reel/Frame 066092/0939 →
Continuity (2)
Continuation 18012956
Related Publication 20240117568A1 · Apr 11, 2024
References Cited (388)
US 2177490A · Kieffer · 1939 [cited by applicant]
US 3337388A · Wosaba · 1967 [cited by applicant]
US 3414459A · Wells · 1968 [cited by applicant]
US 3556907A · Nystrand · 1971 [cited by applicant]
US 3738905A · Thomas · 1973 [cited by applicant]
US 3867225A · Nystrand · 1975 [cited by applicant]
US 3953638A · Kemp · 1976 [cited by applicant]
US 3998690A · Lyness et al. · 1976 [cited by applicant]
US 4181068A · Pollock · 1980 [cited by applicant]
US 4284465A · Walbrun · 1981 [cited by applicant]
US 4320162A · Schulz · 1982 [cited by applicant]
US 4339088A · Niedermeyer · 1982 [cited by applicant]
US 4376671A · Schulz · 1983 [cited by applicant]
US 4487378A · Kobayashi · 1984 [cited by applicant]
US 4671983A · Burt · 1987 [cited by applicant]
US 5468323A · Mcneil · 1995 [cited by applicant]
US 5779860A · Hollenberg · 1998 [cited by applicant]
US 5900114A · Brown et al. · 1999 [cited by applicant]
US 5922439A · Bredenick et al. · 1999 [cited by applicant]
US 6077390A · Salman et al. · 2000 [cited by applicant]
US 6080276A · Burgess · 2000 [cited by applicant]
US 6102313A · Salzsauler et al. · 2000 [cited by applicant]
US 6544386B1 · Krzysik et al. · 2003 [cited by applicant]
US 6551691B1 · Hoeft et al. · 2003 [cited by applicant]
US 6599614B1 · Roussel et al. · 2003 [cited by applicant]
US 6610173B1 · Lindsay et al. · 2003 [cited by applicant]
US 6746558B2 · Hoeft et al. · 2004 [cited by applicant]
US 6805766B1 · Roussel et al. · 2004 [cited by applicant]
US 6913673B2 · Baggot et al. · 2005 [cited by applicant]
US 7026037B2 · Lefebvre et al. · 2006 [cited by applicant]
US 7166189B2 · Burazin et al. · 2007 [cited by applicant]
US 7291379B2 · Biagiotti · 2007 [cited by applicant]
US 7785696B2 · Boatman et al. · 2010 [cited by applicant]
US 7827907B2 · Koivukunnas et al. · 2010 [cited by applicant]
US 7829177B2 · Russell et al. · 2010 [cited by applicant]
US 7842163B2 · Nickel et al. · 2010 [cited by applicant]
US 7967951B2 · Suzuki et al. · 2011 [cited by applicant]
US 7971526B2 · Blenke et al. · 2011 [cited by applicant]
US 7992818B2 · Maddaleni et al. · 2011 [cited by applicant]
US 8158047B2 · Schulz et al. · 2012 [cited by applicant]
US 8425730B2 · Biagiotti · 2013 [cited by applicant]
US 8535780B2 · Wojcik · 2013 [cited by examiner]
US 8597469B2 · Biagiotti · 2013 [cited by applicant]
US 8708020B2 · Schutz · 2014 [cited by applicant]
US 8920905B2 · Sauter et al. · 2014 [cited by applicant]
US 8974892B2 · Nencioni et al. · 2015 [cited by applicant]
US 9034478B2 · Weisang et al. · 2015 [cited by applicant]
US 9090040B2 · Sauter et al. · 2015 [cited by applicant]
US 9284147B2 · Techlin · 2016 [cited by applicant]
US 9365376B2 · Wojcik · 2016 [cited by examiner]
US 9375116B2 · Graff et al. · 2016 [cited by applicant]
US 9458574B2 · Myangiro et al. · 2016 [cited by applicant]
US 9637862B2 · Saas et al. · 2017 [cited by applicant]
US 9663900B2 · Jeannot et al. · 2017 [cited by applicant]
US 10213066B2 · Weisang et al. · 2019 [cited by applicant]
US 10280567B2 · Vogt et al. · 2019 [cited by applicant]
US 10350850B2 · Roesch · 2019 [cited by examiner]
US 10463204B2 · Barredo · 2019 [cited by applicant]
US 10654239B2 · Stefani · 2020 [cited by applicant]
US 10696004B2 · Dettori et al. · 2020 [cited by applicant]
US 10814587B2 · Kleinwaechter et al. · 2020 [cited by applicant]
US 11090900B2 · Kraus et al. · 2021 [cited by applicant]
US 11280051B2 · Satake Neto et al. · 2022 [cited by applicant]
US 11346058B2 · Pleyber et al. · 2022 [cited by applicant]
US 11491699B2 · Yoshimura · 2022 [cited by applicant]
US 11987030B2 · Dwiggins · 2024 [cited by applicant]
US 12018439B2 · Satake Neto et al. · 2024 [cited by applicant]
US 12071730B2 · Pleyber · 2024 [cited by examiner]
US 20020088596A1 · Lamb · 2002 [cited by applicant]
US 20020197346A1 · Papadopoulos · 2002 [cited by applicant]
US 20030026953A1 · Müller · 2003 [cited by applicant]
US 20030111169A1 · Baggot et al. · 2003 [cited by applicant]
US 20030118784A1 · Hollmark · 2003 [cited by applicant]
US 20030129363A1 · Hoeft et al. · 2003 [cited by applicant]
US 20040028935A1 · Hauke · 2004 [cited by applicant]
US 20040166290A1 · Sembritzki et al. · 2004 [cited by applicant]
US 20050098281A1 · Schulz et al. · 2005 [cited by applicant]
US 20050178513A1 · Russell et al. · 2005 [cited by applicant]
US 20060070714A1 · Perini · 2006 [cited by applicant]
US 20060130985A1 · Beuther et al. · 2006 [cited by applicant]
US 20060222819A1 · Gambini · 2006 [cited by applicant]
US 20060283538A1 · Schulz et al. · 2006 [cited by applicant]
US 20070003736A1 · Saarvali et al. · 2007 [cited by applicant]
US 20070062658A1 · Wiwi et al. · 2007 [cited by applicant]
US 20070092700A1 · Maddaleni et al. · 2007 [cited by applicant]
US 20070093157A1 · Shannon et al. · 2007 [cited by applicant]
US 20070137813A1 · Nickel et al. · 2007 [cited by applicant]
US 20070184246A1 · Nencioni et al. · 2007 [cited by applicant]
US 20070218248A1 · Mansson et al. · 2007 [cited by applicant]
US 20090162597A1 · Barredo et al. · 2009 [cited by applicant]
US 20090226670A1 · Schuetz · 2009 [cited by applicant]
US 20090255640A1 · Morin et al. · 2009 [cited by applicant]
US 20090297781A1 · Huss et al. · 2009 [cited by applicant]
US 20100021696A1 · Hill et al. · 2010 [cited by applicant]
US 20100183350A1 · Sauter et al. · 2010 [cited by applicant]
US 20100183850A1 · Sauter et al. · 2010 [cited by applicant]
US 20100224338A1 · Harper et al. · 2010 [cited by applicant]
US 20100229738A1 · Hirota et al. · 2010 [cited by applicant]
US 20100239825A1 · Sheehan et al. · 2010 [cited by applicant]
US 20100295214A1 · Boatman et al. · 2010 [cited by applicant]
US 20110079671A1 · Wojcik · 2011 [cited by examiner]
US 20110123773A1 · Lofink et al. · 2011 [cited by applicant]
US 20120152445A1 · Barredo et al. · 2012 [cited by applicant]
US 20120156447A1 · Hein et al. · 2012 [cited by applicant]
US 20120164426A1 · Barredo et al. · 2012 [cited by applicant]
US 20120244241A1 · Mcneil · 2012 [cited by applicant]
US 20120255671A1 · Wallstabe et al. · 2012 [cited by applicant]
US 20130216789A1 · Kraus et al. · 2013 [cited by applicant]
US 20130327876A1 · Wojcik · 2013 [cited by examiner]
US 20140224919A1 · Bixler et al. · 2014 [cited by applicant]
US 20150184342A1 · Saas et al. · 2015 [cited by applicant]
US 20150225903A1 · Jeannot et al. · 2015 [cited by applicant]
US 20150298420A1 · Gungner et al. · 2015 [cited by applicant]
US 20170274616A1 · Greenfield · 2017 [cited by applicant]
US 20170280946A1 · Weisang et al. · 2017 [cited by applicant]
US 20170328011A1 · Sealey et al. · 2017 [cited by applicant]
US 20180014699A1 · Barredo · 2018 [cited by applicant]
US 20180104928A1 · Dwiggins · 2018 [cited by applicant]
US 20180142422A1 · Baum et al. · 2018 [cited by applicant]
US 20180187377A1 · Ziegenbein · 2018 [cited by applicant]
US 20180216398A1 · Veerasamy · 2018 [cited by applicant]
US 20190061302A1 · Barnholtz et al. · 2019 [cited by applicant]
US 20190063004A1 · Barnholtz · 2019 [cited by applicant]
US 20190078263A1 · Glass et al. · 2019 [cited by applicant]
US 20190136457A1 · Lindsay et al. · 2019 [cited by applicant]
US 20190301099A1 · Montagnani et al. · 2019 [cited by applicant]
US 20200011014A1 · Pleyber et al. · 2020 [cited by applicant]
US 20200156891A1 · Kurosaki · 2020 [cited by applicant]
US 20200263361A1 · Weisang · 2020 [cited by applicant]
US 20200277737A1 · Weisang · 2020 [cited by applicant]
US 20200298525A1 · Dwiggins · 2020 [cited by applicant]
US 20200324506A1 · Picchi et al. · 2020 [cited by applicant]
US 20200384718A1 · Picchi et al. · 2020 [cited by applicant]
US 20210070005A1 · Kumar et al. · 2021 [cited by applicant]
US 20210122561A1 · Lemke et al. · 2021 [cited by applicant]
US 20210180260A1 · Satake Neto et al. · 2021 [cited by applicant]
US 20210292972A1 · Lecount et al. · 2021 [cited by applicant]
US 20210310197A1 · Lecount et al. · 2021 [cited by applicant]
US 20210381172A1 · Goulet et al. · 2021 [cited by applicant]
US 20220010498A1 · Pleyber et al. · 2022 [cited by applicant]
US 20220112642A1 · Giurlani et al. · 2022 [cited by applicant]
US 20220154409A1 · Curley et al. · 2022 [cited by applicant]
US 20220168925A1 · Giurlani et al. · 2022 [cited by applicant]
US 20220275584A1 · Satake Neto · 2022 [cited by examiner]
US 20230146893A1 · Pieroni · 2023 [cited by examiner]
US 20230287630A1 · Weisang · 2023 [cited by examiner]
US 20240117566A1 · Skarius et al. · 2024 [cited by applicant]
US 20240117568A1 · Weisang · 2024 [cited by examiner]
US 20240209575A1 · Bailey · 2024 [cited by examiner]
US 20250092609A1 · Jeannot · 2025 [cited by examiner]
US 20250116069A1 · Weisang · 2025 [cited by examiner]
US 20250250743A1 · Weisang et al. · 2025 [cited by applicant]
US 20250250744A1 · Weisang et al. · 2025 [cited by applicant]
AU 2010304761A1 · 2012 [cited by examiner]
CA 2049552A1 · 1992 [cited by applicant]
CA 2096140A1 · 1993 [cited by applicant]
CA 2776477C · 2018 [cited by applicant]
CL 200501067 · 2006 [cited by applicant]
CL 200803570 · 2009 [cited by applicant]
CL 202101610 · 2021 [cited by applicant]
CL 202203775 · 2022 [cited by applicant]
CL 202300009 · 2023 [cited by applicant]
CL 202300010 · 2023 [cited by applicant]
CN 1326523A · 2001 [cited by applicant]
CN 102574354A · 2012 [cited by applicant]
CN 104136683A · 2014 [cited by applicant]
CN 104302471A · 2015 [cited by applicant]
CN 104520506A · 2015 [cited by applicant]
CN 107250013A · 2017 [cited by applicant]
CN 207954831U · 2018 [cited by applicant]
CN 110268116A · 2019 [cited by applicant]
CN 110914037A · 2020 [cited by applicant]
CN 210362711U · 2020 [cited by applicant]
CN 111727288A · 2020 [cited by applicant]
CN 112218985A · 2021 [cited by applicant]
CN 115715342A · 2023 [cited by examiner]
CN 115735031A · 2023 [cited by applicant]
CN 118541524A · 2024 [cited by applicant]
CO 5031318A1 · 2001 [cited by applicant]
CO 5200825A1 · 2002 [cited by applicant]
CO 5650179A2 · 2006 [cited by applicant]
DE 10137116A1 · 2003 [cited by applicant]
DE 20313418U1 · 2003 [cited by applicant]
DE 102005055707A1 · 2007 [cited by applicant]
EP 0264676A1 · 1988 [cited by applicant]
EP 338792A2 · 1989 [cited by applicant]
EP 426288A2 · 1991 [cited by applicant]
EP 499942A2 · 1992 [cited by applicant]
EP 668152A1 · 1995 [cited by applicant]
EP 739708A2 · 1996 [cited by applicant]
EP 0701641B1 · 1997 [cited by applicant]
EP 0668152B1 · 1998 [cited by applicant]
EP 934738A1 · 1999 [cited by applicant]
EP 1081284A1 · 2001 [cited by applicant]
EP 1208965A2 · 2002 [cited by applicant]
EP 0813382B1 · 2002 [cited by applicant]
EP 1321570A2 · 2003 [cited by applicant]
EP 1321576A2 · 2003 [cited by applicant]
EP 1338412A1 · 2003 [cited by applicant]
EP 1400199A · 2004 [cited by applicant]
EP 1464263A1 · 2004 [cited by applicant]
EP 1907199A1 · 2008 [cited by applicant]
EP 1996395A1 · 2008 [cited by applicant]
EP 2044264A1 · 2009 [cited by applicant]
EP 2095935A1 · 2009 [cited by applicant]
EP 2261420A1 · 2010 [cited by applicant]
EP 2292840A1 · 2011 [cited by applicant]
EP 2353859B1 · 2011 [cited by applicant]
EP 2360015A1 · 2011 [cited by applicant]
EP 2664451A1 · 2013 [cited by applicant]
EP 2692948A1 · 2014 [cited by applicant]
EP 2754553A2 · 2014 [cited by applicant]
EP 2884001A1 · 2015 [cited by applicant]
EP 2998436A1 · 2016 [cited by applicant]
EP 3143203A1 · 2017 [cited by applicant]
EP 2485973B1 · 2017 [cited by examiner]
EP 2925202B1 · 2019 [cited by applicant]
EP 4166314A2 · 2023 [cited by applicant]
EP 4176125B1 · 2024 [cited by applicant]
EP 4077808B1 · 2025 [cited by applicant]
EP 4176124B1 · 2025 [cited by applicant]
ES 2295354T3 · 2008 [cited by applicant]
ES 2339668T3 · 2010 [cited by applicant]
ES 2578830A2 · 2016 [cited by applicant]
ES 2990036T3 · 2024 [cited by applicant]
GB 1259521A · 1972 [cited by applicant]
GB 2255745A · 1992 [cited by applicant]
IT MI951197A1 · 1996 [cited by applicant]
IT 201800006097A1 · 2019 [cited by applicant]
JP 2006045690A · 2007 [cited by applicant]
JP 2007136861A · 2007 [cited by applicant]
JP 2008094067A · 2008 [cited by applicant]
JP 2008138310A · 2008 [cited by applicant]
JP 4649118B2 · 2011 [cited by applicant]
JP 2012110407A · 2012 [cited by applicant]
JP 2015074098A · 2015 [cited by applicant]
JP 2019188021A · 2019 [cited by applicant]
JP 2020072992A · 2020 [cited by applicant]
MX 2014012792A · 2015 [cited by applicant]
WO 9406623A1 · 1994 [cited by applicant]
WO 9711228A1 · 1997 [cited by applicant]
WO 9720107A1 · 1997 [cited by applicant]
WO 9733043A1 · 1997 [cited by applicant]
WO 9743483A1 · 1997 [cited by applicant]
WO 9743484A1 · 1997 [cited by applicant]
WO 9821410A1 · 1998 [cited by applicant]
WO 9847706A1 · 1998 [cited by applicant]
WO 9915332A1 · 1999 [cited by applicant]
WO 9923290A1 · 1999 [cited by applicant]
WO 9923299A1 · 1999 [cited by applicant]
WO 9936253A1 · 1999 [cited by applicant]
WO 9945205A1 · 1999 [cited by applicant]
WO 9953140A1 · 1999 [cited by applicant]
WO 9959511A2 · 1999 [cited by applicant]
WO 0061358A1 · 2000 [cited by applicant]
WO 0125537A1 · 2001 [cited by applicant]
WO 0147699A1 · 2001 [cited by applicant]
WO 0148314A2 · 2001 [cited by applicant]
WO 0202869A2 · 2002 [cited by applicant]
WO 02103112A1 · 2002 [cited by applicant]
WO 03043806A2 · 2003 [cited by applicant]
WO 03045681A1 · 2003 [cited by applicant]
WO 03059139A1 · 2003 [cited by applicant]
WO 03072344A1 · 2003 [cited by applicant]
WO 2004042142A1 · 2004 [cited by applicant]
WO 2004094726A1 · 2004 [cited by applicant]
WO 2005064044A1 · 2005 [cited by applicant]
WO 2005080677A2 · 2005 [cited by applicant]
WO 2005095100A1 · 2005 [cited by applicant]
WO 2006133389A2 · 2006 [cited by applicant]
WO 2007030592A2 · 2007 [cited by applicant]
WO 2007046124A1 · 2007 [cited by applicant]
WO 2007070129A1 · 2007 [cited by applicant]
WO 2007071734 · 2007 [cited by applicant]
WO 2007078363A1 · 2007 [cited by applicant]
WO 2007103433A2 · 2007 [cited by applicant]
WO 2008048151A1 · 2008 [cited by applicant]
WO 2008069147A1 · 2008 [cited by applicant]
WO 2010009769A1 · 2010 [cited by applicant]
WO 2010023616A2 · 2010 [cited by applicant]
WO 2010086837A2 · 2010 [cited by applicant]
WO 2010135074A1 · 2010 [cited by applicant]
WO 2010139759A1 · 2010 [cited by applicant]
WO WO2011042818A2 · 2011 [cited by examiner]
WO 2011078755A1 · 2011 [cited by applicant]
WO 2013179109A2 · 2013 [cited by applicant]
WO 2014020424A1 · 2014 [cited by applicant]
WO 2015175281A1 · 2015 [cited by applicant]
WO 20150186052A1 · 2015 [cited by applicant]
WO 2016132168A1 · 2016 [cited by applicant]
WO 2016159966A1 · 2016 [cited by applicant]
WO 2017019421A1 · 2017 [cited by applicant]
WO 2017037273A1 · 2017 [cited by applicant]
WO 2017134846A1 · 2017 [cited by applicant]
WO 2017168195A1 · 2017 [cited by applicant]
WO 2017196516A1 · 2017 [cited by applicant]
WO 2017197405A1 · 2017 [cited by applicant]
WO 2017209738A1 · 2017 [cited by applicant]
WO 201873985A1 · 2018 [cited by applicant]
WO 2018166572A1 · 2018 [cited by applicant]
WO 2018217599A1 · 2018 [cited by applicant]
WO 2018217602A1 · 2018 [cited by applicant]
WO 2018229676A1 · 2018 [cited by applicant]
WO 201904225A1 · 2019 [cited by applicant]
WO 201959180A1 · 2019 [cited by applicant]
WO 2019064044A1 · 2019 [cited by applicant]
WO 2019064045A1 · 2019 [cited by applicant]
WO 2019064046A1 · 2019 [cited by applicant]
WO 2019203699A1 · 2019 [cited by applicant]
WO 2019219168A1 · 2019 [cited by applicant]
WO 2020068839A1 · 2020 [cited by applicant]
WO 2020128551A1 · 2020 [cited by applicant]
WO 2021126026A1 · 2021 [cited by applicant]
WO WO2022003383A1 · 2022 [cited by examiner]
WO 2024226558A1 · 2024 [cited by applicant]
CN Office Action with English Translation; CN Application No. 202180047021.7; Date Mailed: Feb. 24, 2024; pp. 1-7. [cited by applicant]
Chinese Application No. 202080102390.7; Chinese Office Action with English translation dated Aug. 1, 2023; 18 pages. [cited by applicant]
Chinese Application No. 202080102393.0; Office Action with English translation dated Sep. 20, 2023; 11 pages. [cited by applicant]
Chinese Application No. 202080102449.2; Chinese Office Action with English translation dated Sep. 7, 2023; 20 pages. [cited by applicant]
Chinese Application No. 202180047021.7; Chinese Office Action with English translation dated Sep. 22, 2023; 28 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/IB2020/000586; International Filing Date: Jul. 3, 2020; Date of Mailing: Sep. 29, 2022; 25 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000583; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 24, 2021; 13 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000586; International Filing Date: Jul. 3, 2020; Date of Mailing: Mar. 9, 2021; 12 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000588; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 22, 2021; 11 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000589; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 24, 2021; 11 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000592; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 26, 2021; 15 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000595; International Filing Date: Jul. 3, 2020; Date of Mailing: Apr. 7, 2021; 17 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2021/000458; International Filing Date: Jul. 2, 2021; Date of Mailing: Nov. 2, 2021; 19 pages. [cited by applicant]
Written Opinion of the International Preliminary Examining Authority for International Application No. PCT/IB2020/000586; International Filing Date: Jul. 3, 2020; Date of Mailing: May 19, 2022; 8 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Notice of Allowance mailed Mar. 18, 2024; 97pages. [cited by applicant]
Chilean Application No. 202203663; CL Office Action with English translation dated Jan. 8, 2024; 19 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Non-Final Office Action mailed Jun. 23, 2023; 186 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Notice of Allowance dated Sep. 20, 2023; 8 pages. [cited by applicant]
Chinese Application No. 202080102449.2; Chinese Office Action with English translation dated Feb. 3, 2024; 38 pages. [cited by applicant]
Mexican Application No. MX/E/2023/050579; Third Party Observation dated Jul. 17, 2023; 100 pages. [cited by applicant]
Mexican Application No. MX/E/2023/050580; Third Party Observation dated Jul. 17, 2023; 50 pages. [cited by applicant]
Chinese Application No. 202080102451.X; First Office Action dated Dec. 23, 2023; 29 pages. [cited by applicant]
Colombian Office Action NC2023/0001170; Office Action with English translation dated Aug. 20, 2024; 19 pages. [cited by applicant]
Colombian Patent Office, Office Action issued in CO NC2019/0010000 dated Aug. 9, 2021 with partial English Translation (15 apges). [cited by applicant]
International Searching Authority, Search Report and Written Opinion issued in International Application No. PCT/EP2017/055795 mailed Nov. 9, 2017 (14 pages). [cited by applicant]
National Intellectual Property Administration (Cnipa) of the People's Republic of China, Office Action issued in App. No. 201780086232.5 dated Nov. 19, 2021 with English Translation (17 pages). [cited by applicant]
U.S. Appl. No. 16/491,006; Notice of Allowance dated Feb. 4, 2022; 34 pages. [cited by applicant]
U.S. Appl. No. 18/012,955; Non-Final Office Action dated Nov. 5, 2024; 204 pages. [cited by applicant]
U.S. Appl. No. 18/013,735; Non-Final Office Action dated Nov. 4, 2024; 88 pages. [cited by applicant]
U.S. Appl. No. 18/012,966; Non-Final Office Action dated Aug. 29, 2024; 68 pages. [cited by applicant]
Chilean Application No. 202203662; CL Office Action with English translation dated Aug. 16, 2024; 18 pages. [cited by applicant]
Chinese Application No. 202080102548.0; Office Action with English translation dated Sep. 12, 2024; 28 pages. [cited by applicant]
U.S. Appl. No. 18/012,956; Non-Final Office Action dated Sep. 28, 2024; 22 pages. [cited by applicant]
Chilean Application No. 202203662; CL Office Action with English translation dated Mar. 21, 2024; 20 pages. [cited by applicant]
Chinese Application No. 202080102548.0; First Office Action dated Apr. 3, 2024; 25 pages. [cited by applicant]
Chilean Application No. 202203775; Office Action with English dated Sep. 5, 2024; 35 pages. [cited by applicant]
U.S. Appl. No. 18/013,667; Restriction Requirement dated Sep. 17, 2024; 8 pages. [cited by applicant]
Chilean Application No. 202300008; Office Action with English translation dated Nov. 20, 2024; 25 pages. [cited by applicant]
Chilean Application No. 202300010; Office Action with English translation dated Nov. 14, 2024; 31 pages. [cited by applicant]
Chinese Application No. 202080102451X; Office Action with English translation dated Jan. 15, 2025; 31 pages. [cited by applicant]
Chinese Application No. 2020801025480; Office Action with English translation dated Jan. 3, 2025; 21 pages. [cited by applicant]
Colombian Application No. NC2022/0017942; Office Action with English translation dated Oct. 30, 2024; 29 pages. [cited by applicant]
Colombian Application No. NC2022/0018141; Office Action with English translation dated Oct. 30, 2024; 15 pages. [cited by applicant]
Colombian Application No. NC2023/0001168; Office Action with English translation dated Sep. 12, 2024; 24 pages. [cited by applicant]
Colombian Patent Application No. NC2023/0001172; Office Action with English translation dated Aug. 27, 2024; 16 pages. [cited by applicant]
Ukraine Application No. 22546/3A/24; Office Action with English translation dated Nov. 13, 2024; 13 pages. [cited by applicant]
U.S. Appl. No. 18/012,956; Final Office Action dated Feb. 14, 2025; 30 pages. [cited by applicant]
Chilean Application No. 202300009; Office Action with English translation dated Nov. 12, 2024; 34 pages. [cited by applicant]
Chinese Application No. 202080102451X; Decision of Rejection dated Jan. 15, 2025; 31 pages. [cited by applicant]
Colombian Application No. NC2022/0018141; Office Action with English translation dated Feb. 25, 2025; 20 pages. [cited by applicant]
U.S. Appl. No. 18/724,456; Non-Final Office Action dated May 5, 2025; 264 pages. [cited by applicant]
U.S. Appl. No. 18/012,956; Final Office Action dated Apr. 22, 2025; 27 pages. [cited by applicant]
U.S. Appl. No. 18/012,966; Final Office Action dated Apr. 16, 2025; 22 pages. [cited by applicant]
Singapore Application No. 11202261481U; Office Action dated Apr. 29, 2025; 5 pages. [cited by applicant]
U.S. Appl. No. 18/013,817; Final Office Action dated May 5, 2025; 18 pages. [cited by applicant]
Chilean Application No. 202300011; Office Action dated Apr. 7, 2025; 36 pages. [cited by applicant]
Chinese Application No. 202080102647.9; Office Action dated May 1, 2025; 26 pages. [cited by applicant]
Singapore Application No. 11202261586X; Written Opinion dated Apr. 29, 2025; 5 pages. [cited by applicant]
U.S. Appl. No. 18/013,703; Non-Final Office Action dated Jun. 9, 2025; 130 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Notice of Allowance dated Jul. 8, 2025; 14 pages. [cited by applicant]
Chemical Technology of Pulp and Papermaking, 3rd edition, vol. 2, edited by J.P. Kathy (US), Light Industry Press, Mar. 1988, p. 365-366; With English Translation; 33 pages. [cited by applicant]
Chinese Application No. 202080102451.X; Office Action with English translation dated Jul. 21, 2025; 39 pages. [cited by applicant]
Papermaking II, Drying, by (Finland) Komanku et al., China Light Industry Press, Jul. 2018, pp. 128-130; 13 pages. [cited by applicant]
Ukraine Application No. a 2022 04975; Office Action with English translation dated Jun. 23, 2025; 13 pages. [cited by applicant]
U.S. Appl. No. 18/013,817; Non-Final Office Action dated Aug. 11, 2025; 16 pages. [cited by applicant]
Papermaking II, Drying, by (Finland) Komanku et al., China Light Industry Press, Jul. 2018, pp. 128-130; 22 pages. [cited by applicant]
U.S. Appl. No. 18/724,456; Final Office Action dated Sep. 25, 2025; 70 pages. [cited by applicant]
U.S. Appl. No. 18/012,966; Non-Final Office Action dated Sep. 10, 2025; 38 pages. [cited by applicant]
Colombian Patent Application No. NC2022/0017941; Office Action with English translation dated Sep. 22, 2025; 10 pages. [cited by applicant]
Columbian Office Action, Application No. PCT/IB2020/000588, mailed Sep. 30, 2025; with English translation, 30 pages. [cited by applicant]
Columbian Office Action, Application No. NC2023/0001172, mailed Oct. 1, 2025, with English Translation, 23 pages. [cited by applicant]
Mexican Office Action, Application No. MX/a/2024/008090, mailed Janury 8, 2026, with English Translation, 34 pages. [cited by applicant]
National Intellectual Property Administration (CNIPA) of the People's Republic of China, Application No. 202180105263.7 mailed Jan. 15, 2026, with English Translation, 13 pages. [cited by applicant]